Trial intelligence / Profile preview

Estriol-lactobacilli combination vs polycarbophil-based vaginal moisturizer for post-radiation vaginitis in cervical cancer

TCTR20240510001Phase 3Completed

Sponsor
Songklanagarind Hospital
Start
Aug 2024
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of estriol, polycarbophil vaginal moisturizer in vaginitis, Cervical Cancer (CC), sponsored by Songklanagarind Hospital. Started Aug 2024; status: completed.

02

Drugs

estriolpolycarbophil vaginal moisturizer
03

Conditions

vaginitisCervical Cancer (CC)

Beyond the preview

Go deeper on TCTR20240510001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20240510001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call